Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,136 | -7,625 | -13,043 | -7,792 | -3,388 |
| Depreciation Amortization | 384 | 397 | 6,696 | 1,849 | 151 |
| Accounts receivable | N/A | 32 | 3 | -12 | -24 |
| Accounts payable and accrued liabilities | 169 | 144 | -294 | 545 | -76 |
| Other Working Capital | 377 | -199 | -578 | 1,093 | -63 |
| Other Operating Activity | 528 | 1,355 | 860 | 113 | -18 |
| Operating Cash Flow | $-7,677 | $-5,896 | $-6,356 | $-4,202 | $-3,417 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -180 | -364 | -12 | 155 | 495 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -370 |
| Other Investing Activity | 0 | 0 | 0 | 10 | -868 |
| Investing Cash Flow | $-180 | $-364 | $-12 | $165 | $-373 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 313 | N/A | 3,326 | 3,150 | 188 |
| Debt Repayment | N/A | N/A | -1,246 | -175 | -187 |
| Common Stock Issued | 3,556 | 5,637 | 7,657 | 0 | N/A |
| Other Financing Activity | 11,206 | 0 | -707 | 1,082 | 2,260 |
| Financing Cash Flow | $15,075 | $5,637 | $9,031 | $4,058 | $2,261 |
| Beginning Cash Position | 2,117 | 2,741 | 78 | 57 | 1,585 |
| End Cash Position | 9,335 | 2,117 | 2,741 | 78 | 57 |
| Net Cash Flow | $7,217 | $-623 | $2,663 | $21 | $-1,529 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,677 | -5,896 | -6,356 | -4,202 | -3,417 |
| Capital Expenditure | -180 | -364 | -12 | -11 | -3 |
| Free Cash Flow | -7,858 | -6,260 | -6,368 | -4,213 | -3,421 |